Published in Clin Cases Miner Bone Metab on September 01, 2010
Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08
Antifracture drugs consumption in Tuscany Region before the Target Project: a valuable model for the analysis of administrative database. Clin Cases Miner Bone Metab (2012) 0.85
The role of the orthopaedic surgeon in the prevention of refracture in patients treated surgically for fragility hip and vertebral fracture. Clin Cases Miner Bone Metab (2014) 0.75
The T.A.R.Ge.T. project: a regional program to reduce hip fracture in elderly patients. Main results of retrospective phase. Clin Cases Miner Bone Metab (2015) 0.75
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Factors associated with mortality after hip fracture. Osteoporos Int (2000) 2.35
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24
The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int (2003) 2.22
Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54
Health-related quality of life and self-reported ability concerning ADL and IADL after hip fracture: a randomized trial. Acta Orthop (2006) 1.12
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab (2012) 2.87
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res (2008) 2.66
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 2.38
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res (2012) 2.34
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.98
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med (2006) 1.68
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res (2013) 1.68
Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol (2009) 1.67
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J (2007) 1.67
Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res (2012) 1.58
Natriuretic peptides in heart failure: where we are, where we are going. Intern Emerg Med (2010) 1.51
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Menopause (2013) 1.47
Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab (2003) 1.47
Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement. J Rheumatol (2005) 1.46
The occurrence of acute myocardial infarction in Italy: a five-year analysis of hospital discharge records. Aging Clin Exp Res (2010) 1.44
The role of estrogens in melanoma and skin cancer. Carcinogenesis (2009) 1.38
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res (2002) 1.29
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab (2012) 1.27
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab (2004) 1.25
Multiple endocrine neoplasia type 2. Orphanet J Rare Dis (2006) 1.23
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol (2002) 1.21
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20
Calcium sensing receptor signalling in physiology and cancer. Biochim Biophys Acta (2012) 1.19
Early intra-intensive care unit psychological intervention promotes recovery from post traumatic stress disorders, anxiety and depression symptoms in critically ill patients. Crit Care (2011) 1.18
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J (2006) 1.15
Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res (2006) 1.13
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg (2007) 1.10
Epidemiology of fragility fractures in Italy. Clin Cases Miner Bone Metab (2011) 1.10
Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res (2011) 1.09
Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori (2003) 1.08
Multiple endocrine neoplasia type 1. Orphanet J Rare Dis (2006) 1.08
Aromatase activity and bone homeostasis in men. J Clin Endocrinol Metab (2004) 1.08
Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol (2010) 1.05
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J Bone Miner Res (2010) 1.04
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med (2009) 1.03
Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol (2007) 1.02
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02
Endocrine actions of osteocalcin. Int J Endocrinol (2013) 1.02
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res (2009) 1.02
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. Thyroid (2008) 1.01
Total knee arthroplasty in patients with hypersensitivity to metals. Int Orthop (2014) 1.00
Muscle-bone interactions: basic and clinical aspects. Endocrine (2013) 1.00
Prevalence of Paget's disease of bone in Italy. J Bone Miner Res (2005) 0.99
Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int (2008) 0.99
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer (2005) 0.97
Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature. Calcif Tissue Int (2013) 0.97
A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis (2013) 0.97
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Drugs Aging (2007) 0.97
Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg (2006) 0.96
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center. BMC Pulm Med (2011) 0.96
Myostatin polymorphisms and age-related sarcopenia in the Italian population. J Am Geriatr Soc (2002) 0.93
Physical activity and bone turnover markers: a cross-sectional and a longitudinal study. Calcif Tissue Int (2008) 0.93
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. J Bone Miner Res (2007) 0.93
Polyostotic form of fibrous dysplasia in a 13 years old Colombian girl showing clinical and biochemical response to neridronate intravenous therapy. Clin Cases Miner Bone Metab (2009) 0.92
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol (2005) 0.92
Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev (2011) 0.91
In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer (2004) 0.91
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care (2014) 0.91
MicroRNA Role in Thyroid Cancer Development. J Thyroid Res (2011) 0.91
Bone vascularization in normal and disease conditions. Front Endocrinol (Lausanne) (2013) 0.91
Selective oestrogen receptor modulators in desmoid tumours. Expert Opin Investig Drugs (2004) 0.90
Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility. Ther Clin Risk Manag (2012) 0.90
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. J Bone Miner Res (2013) 0.89
Characteristics and familial aggregation of Paget's disease of bone in Italy. J Bone Miner Res (2005) 0.89
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". PLoS One (2012) 0.89
Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J Clin Endocrinol Metab (2004) 0.89
Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res (2006) 0.88
Paget's disease of bone in Italy. J Bone Miner Res (2006) 0.88
In vitro differentiation of human mesenchymal stem cells on Ti6Al4V surfaces. Biomaterials (2007) 0.88
Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause (2006) 0.88
Multiple endocrine neoplasms. Best Pract Res Clin Rheumatol (2008) 0.88
Clinical characteristics and evolution of giant cell tumor occurring in Paget's disease of bone. J Bone Miner Res (2015) 0.88
The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records. J Exp Clin Cancer Res (2012) 0.88
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Clin Pract Endocrinol Metab (2008) 0.88
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag (2008) 0.88